AVI ND HB1+IB vakcina A.U.V.
AVI ND HB1+IB vakcina A.U.V.
Authorised
- Avian infectious bronchitis virus, type Massachusetts, strain B-48, Live
- Newcastle disease virus, strain B1 Hitchner, Live
Product identification
Medicine name:
AVI ND HB1+IB vakcina A.U.V.
Active substance:
- Avian infectious bronchitis virus, type Massachusetts, strain B-48, Live
- Newcastle disease virus, strain B1 Hitchner, Live
Target species:
-
Chicken (hen)
Route of administration:
-
Intraocular use
Product details
Active substance and strength:
-
Avian infectious bronchitis virus, type Massachusetts, strain B-48, Live3.00/log 10 50% embryo infective dose1.00unit(s)/dose
-
Newcastle disease virus, strain B1 Hitchner, Live5.50/log 10 50% embryo infective dose1.00unit(s)/dose
Pharmaceutical form:
-
Oral lyophilisate
Withdrawal period by route of administration:
-
Intraocular use
-
Chicken (hen)
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD11
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Hungary
Package description:
- Available only in Hungarian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laprovet Hungary Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laprovet Hungary Kft.
Responsible authority:
- Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet